APA (7th ed.) Citation

Boutry, C., Hastie, A., Diez-Domingo, J., Tinoco, J. C., Yu, C., Andrews, C., . . . Avelino-Silva, T. J. (2022). Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70. Clinical Infectious Diseases, 74(8), 1459. https://doi.org/10.1093/cid/ciab629

Chicago Style (17th ed.) Citation

Boutry, Céline, et al. "Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70." Clinical Infectious Diseases 74, no. 8 (2022): 1459. https://doi.org/10.1093/cid/ciab629.

MLA (9th ed.) Citation

Boutry, Céline, et al. "Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70." Clinical Infectious Diseases, vol. 74, no. 8, 2022, p. 1459, https://doi.org/10.1093/cid/ciab629.